Table of Content

Executive Summary
Scope and Definition

1 Markets
1.1 Market Overview
1.1.1 Workflow of Digital PCR
1.1.2 Comparison of qPCR and dPCR
1.2 Trends: Current and Future Impact Assessment
1.2.1 Integration with Next-Generation Sequencing (NGS)
1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
1.2.3 Increasing Product Launches in d-PCR Ecosystem
1.3 Supply Chain Overview
1.4 Research and Development Review
1.4.1 Patent Filing Trend (by Region)
1.4.2 Patent Filing Trend (by Country)
1.4.3 Patent Filing Trend (by Year)
1.5 Ongoing Digital PCR Clinical Trials
1.6 Regulatory Landscape
1.6.1 U.S.
1.6.2 European Union
1.6.3 Asia Pacific
1.6.3.1 Japan
1.6.3.2 China
1.7 Market Dynamics Overview
1.7.1 Market Drivers
1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
1.7.1.2 Increasing Incidence of Infectious Diseases
1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
1.7.2 Market Restraints
1.7.2.1 High Cost of Platforms Associated with Digital-PCR
1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
1.7.3 Market Opportunities
1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
1.7.3.2 Growing Adoption of dPCR in Emerging Markets

2 Global Digital PCR Market, by Product, $Million, 2023-2034
2.1 Overview
2.2 Systems
2.2.1 Droplet Digital PCR Systems
2.2.2 Chip-Based Digital PCR Systems
2.3 Consumables (Kits, Assays, and Reagents)
2.4 Software and Services

3 Global Digital PCR Maret, by Application, $Million, 2023-2034
3.1 Overview
3.2 Clinical and Research Application
3.2.1 Oncology
3.2.1.1 Solid Tumor
3.2.1.2 Hematological Malignancies
3.2.2 Infectious Diseases
3.2.2.1 Respiratory Infections
3.2.2.2 Gastrointestinal Infections
3.2.2.3 Other Infections
3.2.3 Rare Diseases
3.2.3.1 Inherited Trait Type
3.2.3.2 Acquired Trait Type
3.2.4 Reproductive Genetics
3.2.4.1 Prenatal Diseases
3.2.4.2 Postnatal Diseases
3.2.5 Transplant Diagnostics
3.2.6 Other Clinical and Research Applications
3.3 Environmental Applications
3.4 Other Applications

4 Global Digital PCR Market, by End User, $Million, 2023-2034
4.1 Overview
4.2 Academic and Research Institutes
4.3 Hospitals and Clinics
4.4 Diagnostic Centers
4.5 Pharmaceutical and Biopharmaceutical Companies
4.6 Other End Users

5 Regions
5.1 Regional Summary
5.2 Drivers and Restraints
5.3 North America
5.3.1 Regional Overview
5.3.2 Driving Factors for Market Growth
5.3.3 Factors Challenging the Market
5.3.4 By Application
5.3.5 By End User
5.3.6 U.S.
5.3.7 Canada
5.4 Europe
5.4.1 Regional Overview
5.4.2 Driving Factors for Market Growth
5.4.3 Factors Challenging the Market
5.4.4 By Application
5.4.5 By End User
5.4.6 France
5.4.7 Germany
5.4.8 U.K.
5.4.9 Spain
5.4.10 Italy
5.4.11 Rest-of-Europe
5.5 Asia-Pacific
5.5.1 Regional Overview
5.5.2 Driving Factors for Market Growth
5.5.3 Factors Challenging the Market
5.5.4 Application
5.5.5 By End User
5.5.6 China
5.5.7 Australia
5.5.8 South Korea
5.5.9 Japan
5.5.10 Rest-of-Asia-Pacific
5.6 Latin America
5.6.1 Regional Overview
5.6.2 Driving Factors for Market Growth
5.6.3 Factors Challenging the Market
5.6.4 By Application
5.6.5 By End User
5.6.6 Brazil
5.6.7 Mexico
5.6.8 Rest-of-Latin America
5.7 Middle East and Africa
5.7.1 Regional Overview
5.7.2 Driving Factors for Market Growth
5.7.3 Factors Challenging the Market
5.7.4 By Application
5.7.5 By End User
5.7.6 K.S.A.
5.7.7 Egypt
5.7.8 Rest-of-Middle East and Africa

6 Markets - Competitive Benchmarking & Company Profiles
6.1 Competitive Landscape
6.1.1 Mergers and Acquisitions
6.1.2 Synergistic Activities
6.1.3 Product Launch and Approval Activities
6.1.4 Expansion, Funding, and Other Activities
6.2 Market Share Analysis
6.3 Company Profile
6.3.1 Bio-Rad Laboratories, Inc.
6.3.1.1 Overview
6.3.1.2 Top Products/Product Portfolio
6.3.1.3 Top Competitors
6.3.1.4 Target Customers
6.3.1.5 Key Personnel
6.3.1.6 Analyst View
6.3.2 Thermo Fisher Scientific Inc.
6.3.2.1 Overview
6.3.2.2 Top Products/Product Portfolio
6.3.2.3 Top Competitors
6.3.2.4 Target Customers
6.3.2.5 Key Personnel
6.3.2.6 Analyst View
6.3.3 QIAGEN N.V.
6.3.3.1 Overview
6.3.3.2 Top Products/Product Portfolio
6.3.3.3 Top Competitors
6.3.3.4 Target Customers
6.3.3.5 Key Personnel
6.3.3.6 Analyst View
6.3.4 F. Hoffmann-La Roche Ltd
6.3.4.1 Overview
6.3.4.2 Top Products/Product Portfolio
6.3.4.3 Top Competitors
6.3.4.4 Target Customers
6.3.4.5 Key Personnel
6.3.4.6 Analyst View
6.3.5 Standard BioTools Inc.
6.3.5.1 Overview
6.3.5.2 Top Products/Product Portfolio
6.3.5.3 Top Competitors
6.3.5.4 Target Customers
6.3.5.5 Key Personnel
6.3.5.6 Analyst View
6.3.6 Merck KGaA
6.3.6.1 Overview
6.3.6.2 Top Products/Product Portfolio
6.3.6.3 Top Competitors
6.3.6.4 Target Customers
6.3.6.5 Key Personnel
6.3.6.6 Analyst View
6.3.7 Stilla Technologies Inc.
6.3.7.1 Overview
6.3.7.2 Top Products/Product Portfolio
6.3.7.3 Top Competitors
6.3.7.4 Target Customers
6.3.7.5 Key Personnel
6.3.7.6 Analyst View
6.3.8 SAGA Diagnostics AB
6.3.8.1 Overview
6.3.8.2 Top Products/Product Portfolio
6.3.8.3 Top Competitors
6.3.8.4 Target Customers
6.3.8.5 Key Personnel
6.3.8.6 Analyst View
6.3.9 Naveris, Inc.
6.3.9.1 Overview
6.3.9.2 Top Products/Product Portfolio
6.3.9.3 Top Competitors
6.3.9.4 Target Customers
6.3.9.5 Key Personnel
6.3.9.6 Analyst View
6.3.10 Genetron Holdings Limited
6.3.10.1 Overview
6.3.10.2 Top Products/Product Portfolio
6.3.10.3 Top Competitors
6.3.10.4 Target Customers
6.3.10.5 Key Personnel
6.3.10.6 Analyst View
6.3.11 RevoSketch Inc.
6.3.11.1 Overview
6.3.11.2 Top Products/Product Portfolio
6.3.11.3 Top Competitors
6.3.11.4 Target Customers
6.3.11.5 Key Personnel
6.3.11.6 Analyst View
6.3.12 JN Medsys
6.3.12.1 Overview
6.3.12.2 Top Products/Product Portfolio
6.3.12.3 Top Competitors
6.3.12.4 Target Customers
6.3.12.5 Key Personnel
6.3.12.6 Analyst View
6.3.13 JETA Molecular BV.
6.3.13.1 Overview
6.3.13.2 Top Products/Product Portfolio
6.3.13.3 Top Competitors
6.3.13.4 Target Customers
6.3.13.5 Key Personnel
6.3.13.6 Analyst View
6.3.14 Sysmex Corporation.
6.3.14.1 Overview
6.3.14.2 Top Products/Product Portfolio
6.3.14.3 Top Competitors
6.3.14.4 Target Customers
6.3.14.5 Key Personnel
6.3.14.6 Analyst View

7 Research Methodology
7.1 Data Sources
7.1.1 Primary Data Sources
7.1.2 Secondary Data Sources
7.1.3 Data Triangulation
7.2 Market Estimation and Forecast

List of Figures
Figure 1: Global Digital PCR Market, by Region, $Million, 2023, 2029, and 2034
Figure 2: Global Digital PCR Market (by Product), $Million, 2023, 2029 and 2034
Figure 3: Global Digital PCR Market (by Application), $Million 202, 2029 and 2034
Figure 4: Global Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
Figure 5: Key Events to Keep Track of in the Digital PCR Market
Figure 6: Supply Chain and Risks within the Supply Chain
Figure 7: Global Digital PCR Market (by Region), January 2020-September 2024
Figure 8: Global Digital PCR Market (by Country), January 2020-September 2024
Figure 9: Global Digital PCR Market (by Year), January 2020-September 2024
Figure 10: Impact Analysis of Market Navigating Factors, 2024-2034
Figure 11: U.S. Digital PCR Market, $Million, 2023-2034
Figure 12: Canada Digital PCR Market, $Million, 2023-2034
Figure 13: France Digital PCR Market, $Million, 2023-2034
Figure 14: Germany Digital PCR Market, $Million, 2023-2034
Figure 15: U.K. Digital PCR Market, $Million, 2023-2034
Figure 16: Spain Digital PCR Market, $Million, 2023-2034
Figure 17: Italy Digital PCR Market, $Million, 2023-2034
Figure 18: Rest-of-Europe Digital PCR Market, $Million, 2023-2034
Figure 19: China Digital PCR Market, $Million, 2023-2034
Figure 20: Australia Digital PCR Market, $Million, 2023-2034
Figure 21: South Korea Digital PCR Market, $Million, 2023-2034
Figure 22: Japan Digital PCR Market, $Million, 2023-2034
Figure 23: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2023-2034
Figure 24: Brazil Digital PCR Market, $Million, 2023-2034
Figure 25: Mexico Digital PCR Market, $Million, 2023-2034
Figure 26: Rest-of-Latin America Digital PCR Market, $Million, 2023-2034
Figure 27: K.S.A Digital PCR Market, $Million, 2023-2034
Figure 28: Egypt Digital PCR Market, $Million, 2023-2034
Figure 29: Rest-of-Middle East and Africa Digital PCR Market, $Million, 2023-2034
Figure 30: Strategic Initiatives, January 2019-September 2024
Figure 31: Share of Strategic Initiatives, January 2019-September 2024
Figure 32: Global Digital PCR Market, Mergers and Acquisitions, January 2019-September 2024
Figure 33: Global Digital PCR Market, Synergistic Activities, January 2019-September 2024
Figure 34: Global Digital PCR Market, Product Launch and Approval Activities, January 2019-September 2024
Figure 35: Global Digital PCR Market, Expansion, Funding, and Other Activities January 2019-September 2024
Figure 36: Data Triangulation
Figure 37: Bottom-Up Approach (Segment-Wise Analysis)
Figure 38: Top-Down Approach (Segment-Wise Analysis)
Figure 39: Assumptions and Limitations

List of Tables
Table 1: Market Snapshot
Table 2: Opportunities across Regions
Table 3: Global Digital PCR Market, Share Analysis, 2023
Table 4: Comparison of qPCR and dPCR
Table 5: Global Digital PCR Market, Trend Analysis
Table 6: Global Digital PCR Market, Recent Product Launches
Table 7: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
Table 8: Regulatory Framework
Table 9: Funding Allocated for Precision Medicine to Different Agencies Globally
Table 10: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
Table 11: Global Digital PCR Market (by Product), $Million, 2023-2034
Table 12: Global Digital PCR System Market, (by Type), $Million, 2023-2034
Table 13: Global Digital PCR Market (by Application), $Million, 2023-2034
Table 14: Global Digital PCR Market, Clinical and Research, (by Clinical and Research Applications), $Million, 2023-2034
Table 15: Global Digital PCR Market, Oncology, (by Type), $Million, 2023-2034
Table 16: Global Digital PCR Market, Infectious Disease, (by Type), $Million, 2023-2034
Table 17: Global Digital PCR Market, Rare Disease, (by Type), $Million, 2023-2034
Table 18: Global Digital PCR Market, Reproductive Genetics, (by Type), $Million, 2023-2034
Table 19: Global Digital PCR Market (by End User), $Million, 2023-2034
Table 20: Global Digital PCR Market (by Region), $Million, 2023-2034
Table 21: North America Digital PCR Market (by Application), $Million, 2023-2034
Table 22: North America Digital PCR Market (by End User), $Million, 2023-2034
Table 23: U.S. Digital PCR Market (by Application), $Million, 2023-2034
Table 24: U.S. Digital PCR Market (by End User), $Million, 2023-2034
Table 25: Canada Digital PCR Market (by Application), $Million, 2023-2034
Table 26: Canada Digital PCR Market (by End User), $Million, 2023-2034
Table 27: Europe Digital PCR Market (by Application), $Million, 2023-2034
Table 28: Europe Digital PCR Market (by End User), $Million, 2023-2034
Table 29: France Digital PCR Market (by Application), $Million, 2023-2034
Table 30: France Digital PCR Market (by End User), $Million, 2023-2034
Table 31: Germany Digital PCR Market (by Application), $Million, 2023-2034
Table 32: Germany Digital PCR Market (by End User), $Million, 2023-2034
Table 33: U.K. Digital PCR Market (by Application), $Million, 2023-2034
Table 34: U.K. Digital PCR Market (by End User), $Million, 2023-2034
Table 35: Spain Digital PCR Market (by Application), $Million, 2023-2034
Table 36: Spain Digital PCR Market (by End User), $Million, 2023-2034
Table 37: Italy Digital PCR Market (by Application), $Million, 2023-2034
Table 38: Italy Digital PCR Market (by End User), $Million, 2023-2034
Table 39: Rest-of-Europe Digital PCR Market (by Application), $Million, 2023-2034
Table 40: Rest-of-Europe Digital PCR Market (by End User), $Million, 2023-2034
Table 41: Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
Table 42: Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
Table 43: China Digital PCR Market (by Application), $Million, 2023-2034
Table 44: China Digital PCR Market (by End User), $Million, 2023-2034
Table 45: Australia Digital PCR Market (by Application), $Million, 2023-2034
Table 46: Australia Digital PCR Market (by End User), $Million, 2023-2034
Table 47: South Korea Digital PCR Market (by Application), $Million, 2023-2034
Table 48: South Korea Digital PCR Market (by End User), $Million, 2023-2034
Table 49: Japan Digital PCR Market (by Application), $Million, 2023-2034
Table 50: Japan Digital PCR Market (by End User), $Million, 2023-2034
Table 51: Rest-of-Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
Table 52: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
Table 53: Latin America Digital PCR Market (by Application), $Million, 2023-2034
Table 54: Latin America Digital PCR Market (by End User), $Million, 2023-2034
Table 55: Brazil Digital PCR Market (by Application), $Million, 2023-2034
Table 56: Brazil Digital PCR Market (by End User), $Million, 2023-2034
Table 57: Mexico Digital PCR Market (by Application), $Million, 2023-2034
Table 58: Mexico Digital PCR Market (by End User), $Million, 2023-2034
Table 59: Rest-of-Latin America Digital PCR Market (by Application), $Million, 2023-2034
Table 60: Rest-of-Latin America Digital PCR Market (by End User), $Million, 2023-2034
Table 61: Middle East and Africa Digital PCR Market (by Application), $Million, 2023-2034
Table 62: Middle East and Africa Digital PCR Market (by End User), $Million, 2023-2034
Table 63: K.S.A. Digital PCR Market (by Application), $Million, 2023-2034
Table 64: K.S.A. Digital PCR Market (by End User), $Million, 2023-2034
Table 65: Egypt Digital PCR Market (by Application), $Million, 2023-2034
Table 66: Egypt Digital PCR Market (by End User), $Million, 2023-2034
Table 67: Rest-of-Middle East and Africa Digital PCR Market (by Application), $Million, 2023-2034
Table 68: Rest-of-Middle East and Africa Digital PCR Market (by End User), $Million, 2023-2034
Table 69: Global Digital PCR Market. Market Share Analysis, 2023